CONGRESS FOR VOTERS

Robert Bresnahan (R-PA)

An amendment numbered 1 printed in Part A of House Report 119-130 to require all HHS regulations or guidance documentation to use language that is inclusive of all opioid overdose reversal drugs that have been approved by FDA, instead of referring to brand names.

H.Amdt. 23 · House of Representatives amendment

A Republican amendment with no cosponsors

Changes H.R. 2483 — SUPPORT for Patients and Communities Reauthorization Act of 2025

Last activity — On agreeing to the Bresnahan amendment (A001) Agreed to by voice vote.

Adopted

The House agreed to this amendment, so its changes are part of the bill from here on.

Its path through Congress

  1. Introduced
  2. Passed House
  3. Adopted

What this amendment would do

In Congress's own words: An amendment numbered 1 printed in Part A of House Report 119-130 to require all HHS regulations or guidance documentation to use language that is inclusive of all opioid overdose reversal drugs that have been approved by FDA, instead of referring to brand names.